Rheumatic fever and rheumatic heart disease among children presenting to two referral hospitals in Harare, Zimbabwe

South African Medical Journal

Volumn 105, Issue 5, 2015, Pages 384-388

  Gapu, P ^a   Bwakura Dangarembizi, M ^a   Kandawasvika, G ^a   Kao, D ^b   Bannerman, C ^a   Hakim, J ^a   Matenga, J A ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; AORTA VALVE REGURGITATION; ARTICLE; BACTERIAL ENDOCARDITIS; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART ARRHYTHMIA; HEART MURMUR; HUMAN; HYPERTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LEUKOCYTE COUNT; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; RECURRENT DISEASE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SCHOOL CHILD; SORE THROAT; THORAX RADIOGRAPHY; ZIMBABWE; CLINICAL TRIAL; INCIDENCE; INFANT; MULTICENTER STUDY; PATIENT REFERRAL; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; ZIMBABWE;

EID: 84930006984     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.9076     Document Type: Article

References (36)

1. World Health Organization. Rheumatic Fever and Rheumatic Heart Disease. Report of a WHO Expert Consultation, Geneva, 29 October-1 November 2001. WHO Technical Report Series 923. Geneva: World Health Organization, 2004. [http://whqlibdoc.who.int/trs/WHO_TRS_923.pdf (accessed 3 June 2013).].
2. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357(5):470-476. [http://dx.doi.org/10.1056/NEJMoa065085].
3. Sliwa K, Mocumbi A O. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol 2010;99(2):65-74. [http://dx.doi.org/10.1007/s00392-009-0094-1].
4. Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: Genetics and pathogenesis. Scand J Immunol 2007;66(2-3):199-207. [http://dx.doi.org/10.1111/j.1365-3083.2007.01974.x].
5. Tani LY, Veasy LG, Minich LL, Shaddy RE. Rheumatic fever in children younger than 5 years: Is the presentation different? Pediatrics 2003;112(5):1065-1068. [http://dx.doi.org/10.1542/peds.112.5.1065].
6. Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors. J Paediatr Child Health 2002;38(3):229-234. [http://dx.doi.org/10.1046/j.1440-1754.2002.00772.x].
7. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5(11):685-694. [http://dx.doi.org/10.1016/S1473-3099(05)70267-X].
8. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007;357(5):439-441. [http://dx.doi.org/10.1056/NEJMp078039].
9. Paar JA, Berios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol 2010;105(12):1809-1814. [http://dx.doi.org/10.1016/j.amjcard.2010.01.364].
10. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: Recent advances and current priorities. Heart 2013;99(21):1554–1561. [http://dx.doi.org/10.1136/heartjnl-2013-303896].
11. Chin TK, Chin EM, Siddiqui T, et al. Pediatric rheumatic heart disease. [http://emedicine.medscape.com/article/891897 (accessed 3 June 2013).].
12. Remenyi B, Carapetis JR, Wiber R, Taubert K, Mayosi BM. Position Statement of the World Heart Federation on the Prevention and Control of Rheumatic Heart Disease. Nat Rev Cardiol 2013;10(5):284-292. [http://dx.doi.org/10.1038/nrcardio.2013.34].
13. Mayosi BM, Robertson K, Volmink J, et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006;96(3):246.
14. Engel EM, Zuhlke L, Robertson K. Rheumatic fever and rheumatic heart disease: where are we now in South Africa? SA Heart 2009;6(1):20-23. [http://journal.saheart.org/index.php?journal=SAHJ&page=a rticle&op=view&path%5B%5D=97 (accessed 1 June 2013).].
15. Zuhlke LJ. Rheumatic heart disease and the ASAP programme: Fresh insights into an old disease. CME 2011;29(11):460-462.
16. Steer AC, Kado J, Jenney AWJ, et al. Acute rheumatic fever and rheumatic heart disease in Fiji: Prospective surveillance, 2005-2007. Med J Aust 2009;190(3):133-135.
17. Park MK. Pediatric Cardiology for Practitioners. 5th ed. Philadelphia: Mosby Elsevier, 2008.
18. Lai WW, Geva T, Shirali GS, Frommelt PC, et al. Guidelines and standards for performance of a pediatric echocardiogram: A report of the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 2006;19(12):1413-1430. [http://dx.doi.org/10.1016/j. echo.2006.09.001].
19. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-381. [http://dx.doi.org/10.1016/j.jbi.2008.08.010].
20. Sliwa K, Carrington M, Mayosi BM, et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: Insights from the Heart of Soweto Study. Eur Heart J 2010;31(6):719-727. [http://dx.doi.org/10.1093/eurheartj/ehp530].
21. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: Incidence and progression in the Northern Territory of Australia, 1997-2010. Circulation 2013;128(5):492-501. [http://dx.doi.org/10.1161/CIRCULATIONAHA.113.001477].
22. Ravisha MS, Tullu MS, Kamat JR. Rheumatic fever and rheumatic heart disease: Clinical profile of 550 cases in India. Arch Med Res 2003;34(5):382-387. [http://dx.doi.org/10.1016/S0188-4409(03)00072-9].
23. Bitar FF, Hayek P, Obeid M, Ghazerddine W, Mikati M, Dbaibo GS. Rheumatic fever in children: A 15 year experience in a developing country. Pediatr Cardiol 2000;21(2):119-122. [http://dx.doi. org/10.1007/s002469910017].
24. De Carvallo SM, Dalben I, Corrente JE, Magalhaes CS. Rheumatic fever presentation and outcome: A case series report. Rev Bras Reumatol 2012;52(2):236-246.
25. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011;3(1):67-84. [http://dx.doi.org/10.2147/CLEP.S12977].
26. Smith MT, Lester-Smith D, Zurynski Y, Noonan S, Carapetis JR, Elliot JE. Persistence of acute rheumatic fever in a tertiary children’s hospital. J Paediatr Child Health 2011;47(4):198-203. [http://dx.doi.org/10.1111/j.1440-1754.2010.01935.x].
27. Carceller A, Tapiero B, Rubin E, Miro J. Acute rheumatic fever: 27 year experience from the Montreal’s pediatric tertiary care centers. An Pediatr (Barc) 2007;67(1):5-10. [http://dx.doi.org/10.1157/13108071].
28. Al Quirash M. The pattern of acute rheumatic fever in children: Experience at the Children’s Hospital, Riyadhi, Saudi Arabia. J Saudi Heart Assoc 2009;21(4):215-220. [http://dx.doi.org/10.1016/j.jsha.2009.10.004].
29. Kula S, Saygili A, Tunaoglu S, Olgunturk R. Acute post streptococcal glomerulonephritis and acute rheumatic fever in the same patient: A case report and a review of the literature. Anadolu Kardiyol Derg 2003;3(3):272-274.
30. World Health Organization. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: Report from phase 1 (1986-90). WHO Cardiovascular Diseases Unit and Principal Investigators. Bull World Health Organ 1992;70(2):213-218.
31. World Health Organization. Antibiotic Use for the Prevention and Treatment of Rheumatic Fever and Rheumatic Heart Disease in Children: Report for the Second Meeting of WHO’s Subcommittee of the Expert Committee of the Selection and Use of Essential Medicines. Geneva: WHO, 2008. [http://www.who.int/selection_medicines/committees/subcommittee/2/RheumaticFever_review.pdf. (accessed 25 June 2013).].
32. Lutalo SK, Mabonga N. Experience on follow-up of registered rheumatic fever patients in the Zimbabwean Midlands. Trop Geogr Med 1986;38(3):277-282.
33. Pelajo CF, Lopez-Bernitez JM, Tores JM, de Oliveira SKF. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr Rheumatol Online J 2010;8(1):22. [http://dx.doi.org/10.1186/1546-0096-8-22].
34. Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever – a systematic review. S Afr Med J 2003;93(3):212-218.
35. Mayosi BM. The four pillars of rheumatic heart disease control. S Afr Med J 2010;100(8):506.
36. Geber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 2009;119(11):1541-1551. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.191959].